Correlation Between Visa and Vertex Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Visa and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Visa Class A and Vertex Pharmaceuticals, you can compare the effects of market volatilities on Visa and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Vertex Pharmaceuticals.

Diversification Opportunities for Visa and Vertex Pharmaceuticals

0.72

Correlation Coefficient

Visa  Vertex Pharmaceuticals

Poor diversification

The 3 months correlation between Visa and Vertex is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Vertex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Visa i.e., Visa and Vertex Pharmaceuticals go up and down completely randomly.

Pair Corralation between Visa and Vertex Pharmaceuticals

Taking into account the 90-day investment horizon Visa is expected to generate 2.78 times less return on investment than Vertex Pharmaceuticals. But when comparing it to its historical volatility, Visa Class A is 1.37 times less risky than Vertex Pharmaceuticals. It trades about 0.11 of its potential returns per unit of risk. Vertex Pharmaceuticals is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest  41,065  in Vertex Pharmaceuticals on December 26, 2024 and sell it today you would earn a total of  9,206  from holding Vertex Pharmaceuticals or generate 22.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Visa Class A  vs.  Vertex Pharmaceuticals

Visa Class A

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Vertex Pharmaceuticals

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Vertex Pharmaceuticals are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Vertex Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Visa and Vertex Pharmaceuticals

The main advantage of trading using opposite Visa and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.

The idea behind Visa Class A and Vertex Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.